Archives
-
Panobinostat and Calcineurin Degradation in Myeloma
2026-09-23
The reference study identifies calcineurin catalytic subunit PPP3CA as a therapeutically relevant vulnerability in multiple myeloma and shows that panobinostat promotes its degradation through disruption of HSP90 chaperone support. The findings connect PPP3CA abundance with advanced disease and possible bortezomib resistance, while supporting combined HDAC and calcineurin inhibition as a mechanistically informed strategy.
-
SIRT6, Nucleolar Remodeling, and Proteostasis
2026-09-22
The reference study identifies SIRT6 as a regulator of proteostasis that restrains ribosomal gene activity, nucleolar expansion, and global protein synthesis. Its findings connect chromatin and nucleolar dysregulation to impaired folding capacity, aggregate formation, and neurodegeneration-associated stress intolerance.
-
Phosbind Acrylamide: Phosphate-Binding Reagent
2026-09-22
Phosbind Acrylamide is a phosphate-binding reagent for antibody-free protein phosphorylation analysis by SDS-PAGE. The F4002 formulation is designed for phosphorylated proteins in the 30–130 kDa range and uses MnCl2-mediated mobility shifts under neutral, Tris-glycine electrophoresis conditions.
-
SepM Mutations and S. mutans Interactions
2026-09-21
Liu et al. linked recurrent sepM missense mutations in clinical Streptococcus mutans isolates with stronger inhibition of Streptococcus gordonii and altered SepM–CSP-21 binding. The study combines isolate phenotyping, sequencing, protein-expression analysis, and biochemical affinity measurements to show that the effect is mutation- and pH-dependent, while also defining important limits for interpreting phosphorylation-related readouts.
-
FAISL, Calpain 2, and FAK in TNBC Metastasis
2026-09-21
A 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking calpain 2-mediated proteolysis, thereby promoting triple-negative breast cancer adhesion, growth, and metastasis. The work shifts attention from FAK transcription and kinase activity toward substrate protection and offers a mechanistic framework for studying protease-dependent focal adhesion remodeling.
-
H 89 2HCl in Trigeminal Pain Signaling
2026-09-20
H 89 2HCl can help separate PKA-dependent phosphorylation from broader cAMP and PKC effects in trigeminal mechanobiology. This article translates recent CGRP/SP–Piezo2 findings into a concentration-aware assay strategy while emphasizing selectivity limits and orthogonal validation.
-
Tracing and Disabling Tumor Extracellular Vesicles
2026-09-19
The reference study introduces a palmitic-acid-displayed lipidated nanophotosensitizer that localizes both inside tumor cells and within tumor extracellular vesicles (TEVs). Near-infrared irradiation generated reactive oxygen species in both compartments, enabling concurrent suppression of primary tumor growth and TEV-mediated metastatic communication in multiple female-mouse tumor models.
-
Phosbind Biotin LC Western Blot Guide
2026-09-18
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes when sequence-specific phospho-antibodies are unavailable or unsuitable. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, but it should not be used in aqueous-only protocols or with working solutions kept for long-term storage.
-
Hoechst 33342 in Senescence Assays
2026-09-18
Explore how Hoechst 33342 nuclear stain can strengthen live-cell imaging and flow cytometry workflows for dermal fibroblast senescence research. This guide connects nuclear segmentation with mitochondrial-quality measurements while clarifying what the dye can—and cannot—demonstrate.
-
Lamotrigine Assay Design for Neural and Cardiac Studies
2026-09-17
Discover how Lamotrigine can support rigorous sodium-channel, serotonin, epilepsy, and cardiac research. This guide converts metabolic-assay lessons from a sumatriptan study into practical controls for interpreting Lamotrigine pharmacology without overextending the evidence.
-
SHH, FGF10, and Species-Specific Penile Development
2026-09-17
A 2025 comparative study identifies differential Shh, Fgf10, and Fgfr2 expression as a functional explanation for why guinea pigs form an open urethral groove whereas mice primarily canalize a urethral plate. By combining spatial expression analysis, quantitative PCR, and genital-tubercle culture, the work connects pathway dosage and developmental timing with preputial and urethral morphogenesis.
-
Trelagliptin and PI3K/AKT Signaling in Adipocytes
2026-09-16
The reference study shows that trelagliptin succinate improves insulin-resistance phenotypes in differentiated 3T3-L1 adipocytes by enhancing IRS-1/AKT signaling, GLUT4 membrane localization, and glucose uptake while reducing free fatty acid and resistin release. Its experimental framework provides a useful model for connecting adipokine biology with phosphorylation-dependent insulin signaling, while also highlighting the need for carefully controlled pathway assays.
-
WAY-100635 Workflows for 5-HT1A Research
2026-09-16
WAY-100635 gives researchers a selective pharmacological control for separating 5-HT1A receptor signaling from broader pain, affective, and neuronal effects. This workflow connects receptor binding, functional antagonism, behavioral pharmacology, and imaging-oriented validation while emphasizing practical controls and troubleshooting.
-
Protease and Phosphatase Inhibitor Cocktail Guide
2026-09-15
Preserve both protein abundance and phosphorylation state during macrophage, tissue, and microbial lysate preparation with an EDTA-free 100X formulation. This workflow shows how to protect HMGB1-centered signaling assays while maintaining compatibility with experiments where metal chelation is undesirable.
-
Deferiprone Workflows for Iron-Stress Biology
2026-09-15
Build controlled iron-depletion experiments with Deferiprone for cancer biology, enterocyte metabolism, oxidative stress, and vascular models. This workflow combines dose optimization, time-resolved transcription, metabolic profiling, inflammatory challenge, and iron repletion to distinguish iron-specific effects from nonspecific toxicity.